成人心脏手术患者Sonorheometry Quantra QPlus特征观察性队列研究
该回顾性观察性研究纳入511例成人心脏手术患者,评估Quantra QPlus检测凝血异常的准确性,并探讨体外循环(CPB)和低纤维蛋白原血症对血小板贡献硬度(PCS)与血小板计数关系的影响。结果显示CTH、FCS、PCS对相应实验室异常有高鉴别准确性,且CPB和低纤维蛋白原血症会改变PCS与血小板计数的关系。
要点
- CTH 153秒可鉴别CPB后INR升高,AUC 0.78-0.84。
- FCS 1.5-2.3 hPa可鉴别CPB后低纤维蛋白原血症,AUC 0.88-0.97。
- CPB和低纤维蛋白原血症时,相同PCS对应更高血小板计数。
核心结论
- CTH、PCS和FCS对相应实验室检测异常具有高鉴别准确性。
- CPB和低纤维蛋白原血症会改变PCS与血小板计数的关系,CPB期间及纤维蛋白原低时相同PCS对应更高血小板计数。
研究设计与样本
- 回顾性观察性研究,纳入单中心学术医疗中心511例成人心脏手术患者,时间为2024-2025年常规应用Sonorheometry的第一年。
主要发现
- CPB后CTH 153秒鉴别INR升高,AUC 0.78-0.84(取决于INR截断值)。
- CPB后FCS 1.5-2.3 hPa鉴别低纤维蛋白原血症,AUC 0.88-0.97(取决于纤维蛋白原截断值)。
- CPB后PCS 6.9-12.2 hPa检测血小板减少症,AUC 0.90-0.97(取决于血小板截断值)。
- CPB期间PCS 9.1-12.1 hPa检测相同程度血小板减少症,AUC 0.92-0.98。
- CPB期间(β=1.51)及低纤维蛋白原状态(FCS 1.6-2.3 hPa时β=3.13;FCS≤1.5 hPa时β=4.04)相同PCS对应更高血小板计数。
关键数值与推荐
- CTH 153秒作为CPB后INR升高的鉴别阈值。
- FCS 1.5-2.3 hPa作为CPB后低纤维蛋白原血症的鉴别阈值。
- PCS 6.9-12.2 hPa(CPB后)或9.1-12.1 hPa(CPB期间)作为血小板减少症的鉴别阈值。
临床怎么用
- Quantra QPlus的CTH、FCS和PCS可用于心脏手术围术期快速鉴别凝血异常。
- 解读PCS与血小板计数关系时需考虑CPB和低纤维蛋白原血症的修饰效应。
局限性
- 回顾性观察性研究,单中心学术医疗中心。
- 仅纳入成人心脏手术患者,常规应用Sonorheometry第一年数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Validation of the Quantra QPlus sonorheometry cartridge (Hemosonics Corporation) in cardiac surgical patients is limited. The primary aim of our study was to quantify the accuracy of the Quantra QPlus cartridge in detecting derangements in traditional coagulation tests. Secondarily, we explored whether the relationship between platelet contribution to clot stiffness (PCS) and platelet count was modified by cardiopulmonary bypass (CPB) and hypofibrinogenemia. METHODS: We performed a retrospective observational study of 511 cardiac surgical patients at a single academic medical center during the first year of routine sonorheometry application during and after cardiac surgery (2024-2025). Receiver operating characteristics were applied to the following Quantra QPlus parameters, with paired reference laboratory assays sampled in a 15-minute interval: clot time heparinase (CTH), fibrinogen contribution to clot stiffness (FCS), and PCS. A multivariable linear regression model was used to determine whether the relationship between PCS and platelet count was modified by CPB or hypofibrinogenemia. RESULTS: A CTH value of 153 seconds discriminated elevated international normalized ratio (INR) values post-CPB, with an area under the curve (AUC) from 0.78 to 0.84 depending on the INR cutoff. An FCS of 1.5 to 2.3 hPa discriminated hypofibrinogenemia post-CPB with an AUC from 0.88 to 0.97 depending on the fibrinogen cutoff. A PCS of 6.9 to 12.2 hPa detected thrombocytopenia post-CPB with an AUC from 0.90 to 0.97, depending on the platelet cutoff. In contrast, a PCS of 9.1 to 12.1 hPa detected the same degree of thrombocytopenia on-CPB with an AUC of 0.92 to 0.98. Platelet count was observed to be higher for a given PCS during CPB (β, 1.51) and in hypofibrinogenemic states (β, 3.13 and 4.04 for FCS 1.6-2.3 hPa and ≤1.5 hPa, respectively). CONCLUSIONS: CTH, PCS, and FCS demonstrated high discriminative accuracy for abnormalities in corresponding laboratory assays. CPB and hypofibrinogenemia modified the relationship between PCS and platelet count, with a higher platelet count observed for a given PCS during CPB and when fibrinogen was low.
引用
- Knio ZO, Marche CA, Khan J, et al. Sonorheometry Quantra QPlus Characteristics in Adult Cardiac Surgical Patients: An Observational Cohort Study. Anesth Analg. 2026. PMID: 42485109. doi:10.1213/ANE.0000000000008139
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。